| Genetic markers predicting sulphonylurea treatment outcomes in type 2 diabetes patients: current evidence and challenges for clinical implementation NK Loganadan, HZ Huri, SR Vethakkan, Z Hussein The pharmacogenomics journal 16 (3), 209-219, 2016 | 32 | 2016 |
| Comparative effectiveness of cardiovascular, renal and safety outcomes of second‐line antidiabetic drugs use in people with type 2 diabetes: a systematic review and network … R Sim, CW Chong, NK Loganadan, AYY Fong, L Navaravong, Z Hussein, ... Diabetic Medicine 39 (3), e14780, 2022 | 26 | 2022 |
| Comparison of a chronic kidney disease predictive model for type 2 diabetes mellitus in Malaysia using Cox regression versus machine learning approach R Sim, CW Chong, NK Loganadan, NL Adam, Z Hussein, SWH Lee Clinical kidney journal 16 (3), 549-559, 2023 | 14 | 2023 |
| Clinical and genetic predictors of secondary sulfonylurea failure in Type 2 diabetes patients: the SUCLINGEN study NK Loganadan, HZ Huri, SR Vethakkan, Z Hussein Pharmacogenomics 21 (9), 587-600, 2020 | 7 | 2020 |
| Impact of COVID-19 lockdown on glycemic, weight, blood pressure Control and medication adherence in patients with type 2 diabetes R Sim, CW Chong, NK Loganadan, Z Hussein, NL Adam, SWH Lee Patient preference and adherence, 2109-2117, 2023 | 5 | 2023 |
| Pharmacogenetics of sulfonylurea-induced hypoglycemia in Type 2 diabetes patients: the SUCLINGEN study NK Loganadan, HZ Huri, SR Vethakkan, Z Hussein Pharmacogenomics 22 (16), 1057-1068, 2021 | 5 | 2021 |
| Cost-effectiveness of pharmacist managed medication therapy adherence clinic (MTAC) on type 2 diabetes patients in a Tertiary Hospital in Malaysia NK Loganadan, KY Lim, NM Nur, F Ariffin Pharmacotherapy 32 (10), E270-E270, 2012 | 3 | 2012 |
| Association of Met420del variant of metformin transporter gene SLC22A1 with metformin treatment response in Ethiopian patients with type 2 diabetes A Degaga, S Sirgu, HZ Huri, MS Sim, T Kebede, B Tegene, ... Diabetes, Metabolic Syndrome and Obesity, 2523-2535, 2023 | 2 | 2023 |
| Cost-effectiveness of glucose-lowering therapies as add-on to standard care for people with type 2 diabetes in Malaysia R Sim, CW Chong, NK Loganadan, P Saidoung, NL Adam, Z Hussein, ... Value in Health Regional Issues 38, 9-17, 2023 | 2 | 2023 |
| A Study On The Management Of Uncontrolled Diabetes In Medical Wards Of Hospital Kuala Lumpur NK Loganadan, NS Ab Rahman, F Mokhtar Malaysian Journal of Pharmaceutical Sciences 3 (2), 43-43, 2005 | 2 | 2005 |
| Comparative effectiveness of sodium-glucose co-transporter 2 inhibitors and dipeptidyl peptidase-4 inhibitors on cardiorenal function and treatment adherence: a prevalent new … R Sim, CW Chong, NK Loganadan, NL Adam, Z Hussein, SWH Lee RPS Pharmacy and Pharmacology Reports 2 (3), rqad023, 2023 | 1 | 2023 |
| Association of the Reduced Function Met420del Polymorphism of SLC22A1 with Metformin-Induced Gastrointestinal Intolerance in Ethiopian Patients with Type 2 Diabetes Mellitus A Degaga, S Sirgu, HZ Huri, MS Sim, NK Loganadan, T Kebede, ... Pharmacogenomics and Personalized Medicine, 183-191, 2024 | | 2024 |
| COMPARATIVE-EFFECTIVENESS RESEARCH/HTA T Varela, P Zamorano, P Muñoz, M Espinoza, A Tellez, E Irazoqui, ... | | 2023 |
| Impact of a training program on hospital pharmacists' patient-centered communication attitudes and behaviors YK Ng, NM Shah, TF Chen, NK Loganadan, SH Kong, YY Cheng, ... Exploratory Research in Clinical and Social Pharmacy 11, 100325, 2023 | | 2023 |
| LONG-TERM TREATMENT OUTCOMES WITH GLUCAGON-LIKE-PEPTIDE-1 RECEPTOR AGONIST (GLP-1RA): A REAL-LIFE STUDY AT HOSPITAL PUTRAJAYA V Devaraja, CK Low, VM Valayatham, NK Loganadan, Z Hussein Journal of the ASEAN Federation of Endocrine Societies 38 (S2), 10-10, 2023 | | 2023 |
| COST-EFFECTIVENESS OF GLUCOSE-LOWERING THERAPIES AS ADD-ON TO STANDARD CARE FOR PEOPLE WITH TYPE 2 DIABETES IN MALAYSIA R Sim, CW Chong, NK Loganadan, NL Adam, Z Hussein, SWH Lee VALUE IN HEALTH 25 (12), S58-S58, 2022 | | 2022 |
| IDF21-0069 Beta-cell function and insulin resistance of type 2 diabetes patients on maximum doses of sulphonylurea-metformin NK Loganadan, HZ Huri, SR Vethakkan, Z Hussein Diabetes Research and Clinical Practice 186, 2022 | | 2022 |
| ID 36. Outcome Evaluation on Insulin Injection Technique Education by Pharmacists, among Type 2 Diabetes Mellitus Patients in Hospital Putrajaya. TS Anne, NK Loganadan, NM Hie, M Kasim, SA Syarina, FN Azmi, ... Journal of Pharmacy & Bioallied Sciences 12, 2020 | | 2020 |
| Association of rs5219 KCNJ11 Gene Polymorphism with Pancreatic Beta-Cell Function, Insulin Resistance, and Glycemic Control of Sulfonylurea-treated Malaysian Type 2 Diabetes … NK Loganadan, HZ Huri, SR Vethakkan, Z Hussein DIABETES 65, A428-A428, 2016 | | 2016 |
| Impact of Single Nucleotide Polymorphisms (SNPs) of Type 2 Diabetes (T2D) Genes on Patients' Response to Sulphonylurea Therapy NK Loganadan, HZ Huri, SR Vethakkan, Z Hussein PUBLIC HEALTH GENOMICS 18, 10-11, 2015 | | 2015 |
